Myomo, Inc. Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price
Myomo, Inc. (MYO) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price of $0.05 per share for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-09.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice · last filed 2026-03-09
- Myomo, Inc. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2025 was $0.05, a 0.00% change from fiscal 2024.
- Myomo, Inc. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2024 was $0.05, a 99.93% decline from fiscal 2023.
- Myomo, Inc. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2023 was $69.61, a 657.45% increase from fiscal 2022.
- Myomo, Inc. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2022 was $9.19, a 18280.00% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 9 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 12 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 12 month as first filed |
|---|---|---|---|---|
| 2025-12-31 | $0.05 10-K · filed 2026-03-09 | |||
| 2024-12-31 | $0.05 10-K · filed 2026-03-09 | |||
| 2023-12-31 | $69.61 10-K · filed 2025-03-10 | |||
| 2022-12-31 | $9.19 10-K · filed 2024-03-08 | |||
| 2021-12-31 | $0.05 10-K · filed 2023-03-13 | |||
| 2020-12-31 | $80.55 10-K · filed 2022-03-11 | |||
| 2019-12-31 | $0.05 10-K · filed 2021-03-10 | |||
| 2018-12-31 | $116.10 10-K · filed 2020-03-13 | $3.87 10-K · filed 2019-03-12 | ||
| 2017-12-31 | $0.34 10-K · filed 2019-03-12 | |||
| 2017-09-30 | $2.42 10-Q · filed 2017-11-08 | |||
| 2017-06-30 | $1.05 10-Q · filed 2017-08-14 | |||
| 2016-12-31 | $0.03 10-K · filed 2018-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Envoy Medical, Inc. (COCH) | United States | $0.056B | |
| ALPHA PRO TECH LTD (APT) | $0.052B | 13.63 | |
| Safe Pro Group Inc. (SPAI) | United States | $0.090B | |
| MILESTONE SCIENTIFIC INC. (MLSS) | United States | $0.036B | -6.85 |
| LAKELAND INDUSTRIES INC (LAKE) | United States | $0.104B | -4.21 |
| NutriBand Inc. (NTRB) | United States | $0.109B | |
| Lifeward Ltd. (LFWD) | $0.021B | ||
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B | |
| ENvue Medical, Inc. (FEED) | United States | $0.011B | |
| Bone Biologics Corp (BBLG) | United States | $0.001B |